Ronquest N, La L, Nag A. Characterizing patients with IBD in Japan: epidemiology, symptoms, treatment pathways and humanistic burden. Poster presented at the 2020 Virtual Japan Digestive Disease Week Conference; November 2020.
Ronquest N, La L, Nag A. The economic burden of inflammatory bowel disease in Japan: results from a systematic literature review. Poster presented at the 2020 Virtual Japan Digestive Disease Week Conference; November 2020.
Bhattacharyya D, Chaiyakunapruk N, Chen Y, Ronquest N. Health technology assessment in multi-payer health care systems: challenges and lessons learned in Asia. Presented at the Virtual ISPOR Asia Pacific 2020; September 15, 2020.
Ling W, Nadipelli VR, Aldridge AP, Ronquest NA, Solem CT, Chilcoat H, Albright V, Johnson C, Learned SM, Mehra V, Heidbreder C. Recovery from Opioid Use Disorder (OUD) after monthly long-acting buprenorphine treatment: 12-month longitudinal outcomes from RECOVER, an observational study. J Addict Med. 2020 Sep;14(5):e233-40. doi: 10.1097/ADM.0000000000000647
Ling W, Nadipelli V, Solem C, Ronquest NA, Yeh YC, Heidbreder C, Learned S, Mehra V. Impact of RBP-6000 (depot buprenorphine) on patient-reported life changes: a long-term study. Presented at the Australasian Professional Society on Alcohol and other Drugs 49th Annual Conference; November 7, 2018. Auckland, Australia. Previously presented at the American Society of Addiction Medicine 49th Annual Conference.
Ronquest NA, Willson TM, Montejano LB, Nadipelli VR, Wollschlaeger BA. Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. Subst Abuse Rehabil. 2018 Sep 21;9:59-78. doi: 10.2147/SAR.S150253
Wollschlaeger BA, Ronquest NA, Montejano LB, Wilson TM, Nadipelli VR. Narcotic pain medication and other concomitant medication use before and after buprenorphine maintenance treatment initiation in patients with opioid dependence. Poster presented at the 2016 PAINWeek Conference; September 2016. Las Vegas, NV. [abstract] Postgrad Med. 2018 Aug; 128(Sup2):63-4. doi: 10.1080/00325481.2016.1224633
Ling W, Nadipelli VR, Solem CT, Ronquest NA, Yeh Y, Heidbrede C, Learned SM. Impact of RBP-6000 (depot buprenorphine) on patient-reported outcomes: a long-term study. Poster presented at the American Society of Addiction Medicine 49th Annual Conference; April 13, 2018. San Diego, CA.